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Membrane fusion in eukaryotic cells mediates the biogenesis of 
organelles, vesicular traffic between them, and exo- and endocytosis of 
important signaling molecules, such as hormones and 
neurotransmitters. Distinct tasks in intracellular membrane fusion have 
been assigned to conserved protein systems. Whereas tether proteins 
mediate initial recognition and attachment of membranes, SNARE 
protein complexes are considered as the core fusion engine. They 
provide mechanical energy to distort membranes and drive them 
through a hemifusion intermediate towards the formation of a fusion 
pore1-3. This last step is highly energy-demanding4,5. We combined the in 
vivo and in vitro fusion of yeast vacuoles with molecular simulations to 
show that tether proteins are critical to overcome the final energy barrier 
to fusion pore formation. SNAREs alone drive vacuoles only into 
hemifusion. Tether proteins greatly increase the volume of SNARE 
complexes and deform the site of hemifusion, which lowers the energy 
barrier for pore opening and provides driving force. Thereby, tether 
proteins assume a critical mechanical role in the terminal stage of 
membrane fusion, which is likely to be conserved at multiple steps of 
vesicular traffic. SNAREs and tether proteins should hence be 
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considered as a single, non-dissociable device to drive fusion. The core 
fusion machinery may then be larger and more complex than hitherto 
thought. 
 
SNAREs dock membranes by stepwise assembly into 4-helix bundles. They 
exert mechanical force through their transmembrane domains (TMDs)1,2. This 
induces fusion of the outer leaflets (hemifusion), followed by inner leaflet 
fusion and pore formation. Pore formation can be preceded by full zippering of 
the 4-helix bundle 6. Fusion is often studied with synaptic SNAREs, which use 
unique cofactors to fuse highly curved neurotransmitter vesicles with exquisite 
speed and temporal control7. The membranes in most other fusion reactions 
fuse more slowly, are much less curved, and their SNARE density is lower. 
Fusion driven solely by SNAREs becomes much less effective with increasing 
vesicle diameter and decreasing SNARE density 8,9. Then, multi-subunit 
tether complexes become important. These facilitate membrane contact, 
associate with the SNARE-binding SM proteins10-12 and promote trans-
SNARE pairing. We investigated whether tether complexes enhance the 
fusogenic potential of SNARE complexes, by increasing the force that 
SNAREs transmit to the bilayers, or by lowering the energy barrier for fusion 
pore formation.  
 
HOPS is the tether complex for vacuole and lysosome fusion. Vacuoles from 
cells deleted for the Rab7-GTPase Ypt7 lack HOPS (Extended Data Fig. 1a)13. 
This prevents fusion and pairing between the vacuolar SNAREs Vam3, Vti1, 
Vam7 and Nyv114. Incubating these membranes with soluble, recombinant 
vacuolar Qc-SNARE Vam7 (rVam7) allows to stimulate trans-SNARE pairing. 
Then, the reaction is independent of endogenous Vam7, which must 
otherwise be liberated by Sec18/NSF-dependent disruption of cis-SNARE 
complexes15. Fusion can hence proceed without ATP, avoiding interference 
by the ATP-driven chaperone NSF, which disassembles SNARE complexes 
unless HOPS protects them14. To assay trans-SNARE pairing, we separately 
prepared vacuoles from ypt7D or wildtype strains expressing Nyv1-HA or 
Vam3-myc. We mixed them in fusion reactions with rVam7 and measured 
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trans-SNARE pairing through co-immunoadsorption of Vam3-myc with Nyv1-
HA. Adding rVam7 to ypt7D vacuoles induced similar trans-SNARE pairing as 
in wildtype vacuoles (Fig. 1a,b). We measured content mixing by transfer of a 
45 kDa enzyme between the fusion partners (Extended Data Fig. 2), and lipid 
mixing by fluorescence dequenching through dilution of rhodamine-
phosphatidylethanolamine3,16. The trans-SNARE complexes on ypt7D 
vacuoles failed to induce content mixing (Fig. 1c), whereas lipid mixing was 
similar to wildtype (Fig. 1d,e). Thus, HOPS-free ypt7D vacuoles reached a 
hemifused state but failed to form a fusion pore, or to open it wide enough to 
let the reporter pass. Lipid mixing was sensitive to antibodies targeting the Qa-
SNARE Vam3 or the R-SNARE Nyv1, confirming that the reaction was 
SNARE-dependent. The ypt7D trans-SNARE complexes are probably fully 
zippered, because this is prerequisite for lipid mixing17.  
 
To test the effect of HOPS on pore opening, we accumulated ypt7D vacuoles 
for 60 min in the hemifused state, added purified HOPS or subcomplexes 
thereof (Extended Data Fig. 1b), and assayed content mixing after 15 min of 
further incubation. HOPS is a hexameric complex with a globular SNARE-
binding domain, which contains the SNARE-binding SM-protein Vps33 and its 
interactor Vps16 (Fig. 1f)18. Vps33 (79 kDa) did not stimulate fusion (Fig. 1g), 
whereas the bigger Vps33-Vps16 subcomplex (159 kDa) rescued fusion to 
80% of an untreated wildtype control, which had been incubated under 
standard fusion conditions with ATP. A Vps11-Vps39 subcomplex (240 kDa), 
representing the opposite end of HOPS without a SNARE interaction site, had 
no effect (Fig. 1g). As the biggest structure, HOPS (663 kDa) rescued ypt7D 
fusion to wildtype level. The endosomal CORVET complex, which is of similar 
size as HOPS and shares Vps33 with it11, stimulated fusion as well as HOPS 
(Extended Data Fig. 3). The specificity of these complexes is hence restricted 
to their Rab-GTPase-dependent function in membrane tethering. HOPS had 
not enhanced trans-SNARE pairing beyond the level attained by the 
preincubation with rVam7 (Fig. 1a,b). It did not induce fusion in the absence of 
Vam7, nor upon pre-incubating the vacuoles with antibodies to Vam3 (Fig. 1g, 
Extended Data Fig. 4). Thus, rescue was SNARE-dependent. These results 
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suggest an additional role of HOPS in fusion pore opening, which is 
independent of its known role in facilitating SNARE pairing12,19. 
 
To test whether pore opening might be driven by increased SNARE complex 
volume, we accumulated hemifused ypt7D vacuoles and added CBP-Vps33, 
which does not stimulate pore opening. When we tripled the effective 
molecular mass of Vps33 by adding a monoclonal antibody (150 kDa) to its 
CBP-tag, content mixing increased 5-fold and reached >50% of the wildtype 
signal (Fig. 2a). Antibodies did not stimulate fusion when Vps33 had been 
omitted, nor when Vps33 was used with a non-cognate HA-antibody. CBP-
Vps33 alone decreased content mixing of wildtype vacuoles by 60% and this 
inhibition could be partially overcome by adding CBP-antibodies. This can be 
understood if CBP-Vps33 outcompetes endogenous HOPS for SNARE 
binding but by itself does not add sufficient mass to stimulate fusion.   
 
Next, we replaced HOPS by artificial SNARE-binding proteins, using solely 
polyclonal antibodies to SNAREs (Fig. 2b). When added from the beginning of 
a reaction, SNARE antibodies interfere with trans-SNARE pairing and block 
fusion. To circumvent this block, we first accumulated ypt7D vacuoles in 
hemifusion, with trans-SNARE complexes already formed. Now, anti-Nyv1 or 
anti-Vam3 became strong stimulators. They rescued content mixing to 50% 
when added individually and to 100% when added simultaneously. Wildtype 
vacuoles, which contain sufficient amounts of endogenous HOPS, were 
hardly stimulated by the antibodies. Thus, artificial SNARE ligands substitute 
for HOPS in fusion pore opening in vitro.  
 
Since bivalent antibodies to SNAREs might promote fusion by clustering 
SNARE complexes around a fusion site, we generated monovalent Fab 
fragments from them (Extended Data Fig. 1c). These inhibited fusion and 
trans-SNARE pairing when added before docking (Fig. 2c,d), but they potently 
stimulated content mixing of hemifused vacuoles without affecting trans-
SNARE pairing. Individual use of Fabs to either Vam3 or Nyv1 stimulated 
fusion weakly, probably becaus e Fabs are smaller (56 kDa) than IgGs (150 
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kDa) and their dimensions permit to place no more than two Fabs along a 
SNARE domain. Fabs to a single SNARE may therefore not add sufficient 
volume to SNARE complexes to drive pore opening. Crowding agents20, such 
as Ficoll 400, had no influence, suggesting that bulky SNARE complex 
ligands do not stimulate fusion by molecular crowding (Extended Data Figs. 5, 
3). Thus, HOPS may promote fusion pore formation in vitro by increasing the 
volume of SNARE complexes. 
 
We engineered an in vivo system for recruiting large ligands to SNAREs, 
using FKBP12 and FRB, two domains undergoing rapamycin-induced 
dimerization21. FKBP12 (12 kDa) was attached to the C-terminus of Vam7, 
which is close to the TMDs of the SNARE complex. FRB-GFP (38 kDa) was 
attached to Pfk1, a subunit of the octameric, soluble phosphofructokinase 
(850 kDa), which is unrelated to fusion (Fig. 3a, Extended Data Fig. 1d,e). 
Rapamycin-insensitive tor1-1 cells served as strain background to avoid side 
effects of rapamycin treatment through TOR signaling22. tor1-1 cells have 
multiple vacuoles under normal growth conditions. Rapamycin recruited Pfk1-
FRB-GFP to vacuoles within less than 10 min (Fig. 3b,c). These vacuoles 
fused, significantly reducing their number per cell. Recruitment, but not fusion, 
was observed when FKBP12 was separated from Vam7 by a 35 amino acid 
linker (Fig. 3c). Vam7 lacking FKBP12 induced neither recruitment nor fusion 
(Fig. 3b). Also an FRB-GFP chimera lacking phosphofructokinase did not 
provoke fusion (Extended Data Fig. 6). 
 
HOPS recruitment controls re-fusion of vacuoles following hypertonic shock23. 
Hypertonic shock fragments yeast vacuoles in <5min, Vps41 becomes 
phosphorylated and dissociates into the cytosol, likely together with HOPS24. 
Vacuole recovery requires Vps41 dephosphorylation, reassociation of HOPS 
with vacuoles and fusion. Whereas re-fusion requires >60 min in wildtype 
cells, rapamycin-induced recruitment of Pfk1-FRB-GFP to SNAREs provoked 
premature fusion of these vacuolar fragments, circumventing the physiological 
inactivation of HOPS (Extended Data Fig. 7). Fusion was not observed in cells 
lacking FKBP12 on Vam7, nor when rapamycin was omitted.  
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We explored the influence of bulky SNARE ligands by coarse-grained 
molecular dynamics (Fig. 4a). HOPS features a SNARE-binding domain of 
approximately 12-14 nm diameter, which probably encapsulates the SNARE 
complex11,18 (Fig. 1f). Binding a sphere of the size of this head region to 
SNAREs markedly affects the geometry of the hemifusion stalk (Fig. 4a). The 
stalk restrains the apposed membranes from separating, enforcing strong 
local curvature. We rationalized the acceleration of fusion from the apparent 
work (free energy) required to thin the hemifusion stalk (Fig. 4a,b and SI). 
Progression from hemifusion to pore opening decreases the mutual distance 
of the SNARE C-termini until they associate (Fig. 4a). The presence of a 
HOPS sphere (14 nm) halves the energetic cost of fusion pore opening (from 
67 kBT to 34 kBT) in a tension-less membrane system with 3 SNARE 
complexes (Fig. 4b, Extended Data Fig. 8). Pore nucleation now requires far-
less thinning of the stalk. We attribute the enhanced (non-leaky) fusion pore 
formation to (I) a partial, relative relaxation of the HOPS-induced curvature 
stress (~30 kBT; Fig. 4c, Extended Data Fig. 9), and (II) a geometrical 
advantage because of the pre-existing curvature (Extended Data Fig. 8). 
Smaller contributions can be made by an initial gain in SNARE pulling force 
(Extended Data Fig. 10). HOPS thus stimulates pore opening by steric effects 
on the site of hemifusion. These aspects are elaborated in supplementary 
discussion. 
 
We can understand numerous unexplained findings from this perspective: (1) 
SNARE-associated tether protein complexes (Munc13 and its associated SM 
protein Munc18) are essential for fusion of synaptic vesicles. While this can 
reflect their role in SNARE complex assembly, Munc13/18 might also drive 
fusion itself25. Accordingly, mutations that reduce Munc18 affinity for SNAREs 
change fusion pore dynamics26. (2) Also mutating the yeast Munc18 homolog 
Sec1, which associates with the tether complex exocyst27, reduces exocytosis 
without reducing SNARE complex abundance28,29. (3) On vacuoles, mutations 
compromising Vps33 binding to vacuolar SNAREs impair content mixing more 
than lipid mixing and trans-SNARE pairing16 (4) HOPS also enhances 
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liposome fusion more than trans-SNARE pairing30;  (5) binding to Sec17/a-
SNAP and Sec18/NSF renders trans-SNARE complexes more fusogenic17,31.  
 
Our simulations and experimental observations suggest that bulky SNARE-
ligands can drive fusion irrespective of specific molecular properties, except 
for their size. Since SM proteins and tethering complexes are indispensable 
for fusion in multiple trafficking pathways11, we propose that the driving force 
that they can contribute to fusion is a critical and conserved feature of their 
function. In physiological membranes, SNAREs and the tether/SM protein 
system thus act as an integrated molecular machine, in which tether/SM 
proteins first facilitate SNARE pairing11 and then drive the very last step of 
fusion.  
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Figure Legends 
 
Figure 1: Effect of soluble Vam7 on lipid and content mixing. 
a, b, Trans-SNARE pairing. Vacuoles were isolated from wildtype (BJ3505) or 
isogenic ypt7D cells carrying Vam3-myc or Nyv1-HA. The two vacuole populations 
were mixed and incubated in fusion reactions with ATP, Vam7 and HOPS as 
indicated. Proteins were solubilized, pulled down with anti-HA and analyzed by 
SDS-PAGE and Western blotting (a). Trans-SNARE pairing is assessed by Vam3-
myc co-adsorbed to Nyv1-HA. Bands were quantified (b). c-e, Hemifusion in ypt7D 
vacuoles: Vacuoles from wildtype and ypt7D cells were incubated in ATP-free 
fusion reactions with 600 nM rVam7 and 10 mg/ml BSA. Antibodies (200 nM) had 
been added where indicated. c, Content mixing was determined after 60 min, 
using the activation of pro-alkaline phosphatase by a maturase from the fusion 
partners. d,e, Lipid mixing was followed by dequenching of the fluorescence of Rh-
phosphatidylethanolamine, which had been integrated at self-quenching 
concentrations into one of the fusion partners. f, Structure of HOPS (from18). g, 
Effect of HOPS subcomplexes on content mixing. Vacuoles were incubated in 
fusion reactions as in C for 60 min, with anti-Vam3 where indicated. Then, the 
samples received 400 nM purified (CBP)-tagged HOPS sub-complexes or Vps33 
and were incubated for further 15 minutes before content mixing was assayed. For 
a-e and g, means ± s.d. are shown from n=3 biologically independent experiments. 
  
Figure 2: Fusion pore opening driven by ligands increasing SNARE complex 
size in vitro. 
a, Vps33. Fusion reactions with wildtype and ypt7D vacuoles were started as in Fig. 
1g. After the first 60 min incubation period, samples received recombinant CBP-
Vps33 (400nM), antibodies to CBP or HA (200 nM), or buffer only. After further 15 
min, content mixing was assayed. b, Antibodies. Two-stage fusion reactions were 
performed as in a, but only with rVam7. Antibodies (200 nM) against Vam3, Nyv1 
or Sec18/NSF were added either during the first 60 min incubation (I°) or during 
the second incubation (II°) of 15 min. c, Fab fragments. Experiment as in b, but with 
Fab fragments instead of antibodies. d, Trans-SNARE pairing was assayed using 
tagged strains as in Fig. 1a. Reactions with staged addition of rVam7 and Fabs 
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were run as in c. For all subfigures, means ± s.d. are shown from n=3 biologically 
independent experiments. 
 
Figure 3: Effect of SNARE complex enlargement on vacuole fusion in vivo. 
a, Schematic view of rapamycin-induced FKBP12/FRB-tagged Pfk1-recruitment to 
the SNARE complex without and with a long linker between Vam7 and FKBP12. b, 
c, In vivo vacuole morphology. Logarithmically growing cells, carrying Pfk1-FRB-
GFP and (b) Vam7 or Vam7-2xFKBP12, or (c) Vam7-LL-2xFKBP12 with a 35 
amino acid linker, were stained with the vacuole tracer FM4-64. Cells were 
incubated with 10 µM rapamycin for 10 min where indicated and analyzed by 
spinning disc microscopy. The cells were grouped into three categories according 
to the number of vacuoles visible per cells. 100 cells were analyzed per sample. 
Scale bar: 5 µm. Means and s.d. are shown from n=3 biologically independent 
experiments. 
 
Figure 4: Molecular dynamics simulations on the influence of steric 
constraints at the (hemi-)fusion site.  
a, Simulation setup: Two hemifused membranes in the presence of the SNARE 
complex that is either free or bound to a sphere equivalent to the size of the 
SNARE-binding domain of HOPS (14 nm). The size of 'HOPS' and positioning of 
the SNARE complex are inspired by EM and crystal structures 9,11,18. To enhance 
clarity, only one SNARE complex is illustrated. b, The free-energy of fusion pore 
formation is derived by measuring the work (free energy) required to thin the stalk 
until fusion pore nucleation occurs32 (see Extended Data Fig. 8). Arrows and 
dotted lines indicate the point of pore nucleation. Error bars are calculated via 
Bayesian resampling of 50 overlapping WHAM histograms. Each parental WHAM 
histogram is comprised of >30000 data points (autocorrelation up to ~1500 data 
points).  c, Work distribution reflecting the equilibrium work that HOPS must 
perform to bend the membrane in the presence of a stalk (average work: 115+/- 2 
kBT) or of a fusion pore (average work: 88 +/- 3 kBT), respectively. A reduction of 
~30 kBT indicates that fusion pore formation is associated with release of local 
membrane stress. 
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Methods 
 
Strains and culture conditions 
All strains were grown in either in YPD (yeast extract, peptone, dextrose) 
containing 2% glucose in the presence or absence of G418, or in SC 
(synthetic dextrose) dropout media containing 2% glucose to select for 
auxotrophies. Strains used in this study can be found in Table S1 in 
supplementary information. Primers used can be found in Table S2. Vam7-LL-
2xFKBP12 contains a linker (LL) of 35 amino acids with the sequence 
SGGGGSGGGG SGGGGSGGGG SGGGGSGGGG GAAGG.  
Genetic manipulations: Yeast transformations were carried out using the 
lithium acetate method. Gene deletions and tagging were performed as 
previously established 33,34. Genome-tagging of Vam7 with 2xFKBP12 and LL-
2xFKBP12 was performed starting from the plasmid pTK209, from which GFP 
was removed by double digestion with PacI and AscI restriction enzymes and 
replaced by a 2xFKBP12 coding sequence carrying the same restriction sites. 
The 2xFKBP12 sequence was obtained by gene synthesis (BIOCAT) and 
cloned into a pUC57 vector. pRS415-TEFpr-FRB-GFP was obtained starting 
from a pRS416-S3-FRB-GFP vector (provided by C. Ungermann's group). 
The FRB-GFP coding frame was amplified by PCR using the primers reported 
above and cloned into the pRS415-TEFpr vector using HindIII and SacI 
restriction sites. 
 
Vacuole isolation 
BJ3505 and DKY6281 strains carrying tagged SNAREs were grown in YPD at 
(30°C, 225 rpm) to OD600=1 and harvested (3 min, 5'000 xg). Harvested cells 
were resuspended in reduction buffer (30 mM Tris/Cl pH 8.9, 10 mM DTT) 
and incubated for 5 min at 30°C. After harvesting as described above, cells 
were resuspended in 15 ml digestion buffer (600 mM sorbitol, 50 mM K-
phosphate pH 7.5 in YP medium with 0.2% glucose and 0.1 mg/ml lyticase 
preparation). After 25 min at 30°C, cells were centrifuged (2 min, 5'200 rpm, 
JLA25.5 rotor). The spheroblasts were resuspended in 2 ml 15% Ficoll-400 in 
PS buffer (10 mM PIPES/KOH pH 6.8, 200 mM sorbitol) and 150 µl (for 
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DKY6281-derived strains) or 250 μl (for BJ3505 derivatives) DEAE dextran 
(0.4 mg/ml in PS). After 2 min of incubation at 30°C, the cells were transferred 
to SW41 tubes and overlaid with steps of 8%, 4% and 0% Ficoll-400 in PS. 
Cells were centrifuged for 90 min at 4°C and 30'000 rpm in a SW41 rotor. 
Lyticase had been recombinantly expressed in E.coli RSB805 (provided by Dr. 
Randy Schekman, Berkeley) and prepared from a periplasmic supernatant 3.   
 
Vacuole fusion and content mixing assay 
DKY6281 and BJ3505 vacuoles were adjusted to a protein concentration of 
0.5 mg/ml and incubated in a volume of 30 μl PS buffer (10 mM PIPES/KOH 
pH 6.8, 200 mM sorbitol) with 125 mM KCl, 0.5 mM MnCl2. Note that the 
harvested vacuole suspension contains around 20 mg/ml Ficoll 400, creating 
an environment of moderate molecular crowding 35.  Vacuoles were 
preincubated with inhibitors on ice (5 min) before starting the fusion by 
addition of the ATP-regenerating system (0.25 mg/ml creatine kinase, 20 mM 
creatine phosphate, 500 μM ATP, 500 μM MgCl2) or of 600 nM rVam7 and 10 
mg/ml BSA. Samples were incubated for 60 min at 27°C. In two-stage 
reactions, a second incubation of 15 at 27°C was added, with 200 nM of 
antibodies or 400 nM of purified HOPS subunits. In order to assay fusion, 1 ml 
of PS buffer was added, vacuoles were centrifuged (2 min, 20'000xg, 4°C) 
and resuspended in 500 μl developing buffer (10 mM MgCl2, 0.2% TX-100, 
250 mM Tris-HCl pH 8.9, 1 mM p-nitrophenylphosphate). After 5 min at 27°C, 
the reactions were stopped with 500 μl 1M glycine pH 11.5 and the OD was 
measured at 405 nm. Background activity of pro-Pho8 was assessed through 
a fusion sample kept on ice throughout the incubation period. The value of 
this sample was subtracted from the others. 
 
Lipid mixing assay 
Lipid mixing was assayed as described 3. In brief, 30 µg of unlabeled BJ3505 
vacuoles and 6 µg of rhodamine-labeled phosphoethanolamine DKY6281 
vacuoles were mixed in 190 µl of 0.3 mM MnCl2, 75 mM KCl in PS buffer. 
Inhibitors were pre-warmed to 27°C before being adding to the tubes. Fusion 
reactions were started by adding 9.5 µl of 20x ATP-regeneration system, 
yielding 0.125 mg/ml creatine kinase, 20 mM creatine phosphate, 0.5 mM 
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ATP, 0.5 mM MgCl2. 100 µl were used to assay lipid mixing in a fluorescent 
plate reader at 27°C for 32 min. 80 µl were incubated separately for 60 min 
and then assayed for content mixing by alkaline phosphatase developing 
buffer as described above. 
 
Immunoprecipitations 
Vacuoles from a 1 ml fusion reaction were pelleted (5 min, 6'000 xg,  4°C), 
solubilized for 10 min in lysis buffer (0.5% Triton X-100, 0.5 mM MnCl2, 100 
mM CaCl2, 1 mM PMSF) and centrifuged for 10 min at 12'000 xg and 4°C. 
The supernatant was supplemented with 30 µg of antibody and 25 µl of 
protein-G sepharose and shaken for 60 min at 4°C. The beads were washed 
three times with lysis buffer and suspended in SDS sample buffer. 
 
Gel electrophoresis and Western blot 
Protein samples were dissolved in reducing sample buffer and heated to 
95 °C for 5 minutes. The samples were run on either 10 % or 12.5 % 
polyacrylamide gels. The stacking gels were prepared as follows: 6 % 
acrylamide, 0.16 % bis-acrylamide, 0.1 M Tris pH 6.8, 0.1 % SDS, 0.1 % 
TEMED, 0.05 % ammonium persulfate. Running gels were: 10 % or 12.5 % 
acrylamide, 0.27 % or 0.34 % bis-acrylamide, 0.38 M Tris pH 8.8, 0.1 % SDS, 
0.06 % TEMED, 0.06 % APS. The gels (10 cm/ 8 cm/ 1.5 mm) were run at 
constant current (20-30 mA). Proteins were blotted onto nitrocellulose 
membrane by the semidry method for 80 min at 400 mA. After incubation with 
the primary antibody overnight, signals were detected by secondary 
antibodies coupled to infrared dyes and detected on a LICOR Odyssey 
infrared laser scanner. The files were exported as TIFF and processed in 
adobe illustrator CS3. Band intensity was quantified using densitometry 
software supplied with the Odyssey Infrared Imager. 
 
FM4-64 staining 
Cells were inoculated from a pre-culture in stationary phase and grown 
overnight to logarithmic phase (OD600 between 0.2 and 0.8). After dilution to 
an OD600 of 0.2 in 1 ml culture, FM4-64 (N-(3-Triethylammoniumpropyl)-4-(6-
(4-(Diethylamino) Phenyl) Hexatrienyl) Pyridinium Dibromide) in DMSO was 
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added to a final concentration of 10 µM. Cells were stained for 1 h, followed 
by three washing steps in medium without stain (2 min, 3'000 xg) and a 
subsequent chase of 1 to 2 h in medium without stain, depending on the 
endocytotic capacity of the strain. The cells for microscopy were grown at 
30°C. The temperature was kept constant during staining and visualization. 
Care was taken to analyze cells immediately after their removal from the 
culture tube. 
 
Antibodies and affinity purification 
Sources of monoclonal antibodies were: anti-HA (16B12, MMS-101P, 
Covance); anti-myc (9E11, sc-47694, Santa Cruz Biotechnology). Polyclonal 
antibodies against Vam3, Nyv1, Vam7, Vps39, Ypt7 and GFP had been 
raised by injecting purified recombinant hydrophilic parts of these proteins into 
rabbits. Antibodies were purified from sera. Sera were first heated for 30 
minutes at 56°C to inactivate the complement system, diluted 1:1 in PBS and 
filtered through 0.2μ membranes before being passed onto an activated CH-
sepharose 4B column (GE Healthcare Life Sciences 17-0430-01), which had 
been coupled with the recombinant protein of interest, according to the 
instructions of the manufacturer. The column was washed with 10 bed 
volumes of PBS at 4°C. The antibodies were eluted with 0.2 M glycine-HCl pH 
2.5, 4°C, using a peristaltic pump. Eluted fractions were collected on ice in 1,5 
ml tubes containing 150 μl of 1 M Tris pH 8.8 in order to neutralize the 
samples immediately. Protein concentration in the sample was determined by 
Bradford assay using BSA as a standard. Fractions of interest were pooled, 
transferred into PS buffer (10 mM PIPES-KOH pH 6.8, 200 mM sorbitol) 
containing 150 mM KCl by repeated dilution and re-concentration in  
Amicom®Ultra-15 30K ultrafiltration devices (Millipore). The antibodies were 
finally concentrated to 1-3 mg/ml, aliquoted, flashed frozen in liquid nitrogen 
and kept at -20°C. 
 
Papain digestion and Fab fragment purification 
Antibody digestion with papain was described previously 36. Briefly, 10 mg 
affinity-purified IgG were solubilized in 1 ml buffer A (150 mM NaCl, 1 mM 
EDTA, 25 mM mercaptoethanol, 10 mM NaPi pH 7.3), followed by addition of 
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0.1 mg papain and incubation for 3 h at 37° C. 30 mM iodoacetamide was 
added to inhibit papain (15 min at 37° C). Afterwards, the sample was chilled 
to 4°C and loaded on a protein A agarose column (Pharmacia; 1.5 ml volume), 
which was equilibrated before with buffer B (100 mM KPi, pH 8.0). The Fab-
containing flow-through was dialyzed against H2O and concentrated by 
ultrafiltration through 30 kDa cutoff membranes (Millipore). 
 
Purification of rVam7 
Plasmid pGEX-KT::Vam7 (kind gift from A. Merz, Seattle) was expressed in 
Rosetta 2 (DE3) (Novagen). Bacteria were grown in 2 l LB with 100 µg/ml 
ampicillin and 25 µg/ml chloramphenicol to OD600=1, induced with 1 mM IPTG, 
30°C for 4 h. Cells were harvested and washed with PBSEEG (2 mM EDTA, 1 
mM EGTA, 2 mM DTT, 1 mM PMSF in 1X PBS). The pellet was frozen in 
liquid nitrogen and stored at -80°C. For purification the sample was thawed, 
resuspended in 40 ml PBSEEG, sonicated (2 x 1 min on ice with maximal 
intensity), centrifuged (TI-60 rotor, 64'000 x g, 30 min, 4°C) and the 
supernatant was incubated with 2-3 ml glutathion-sepharose 4B (GE 
Healthcare, 17-0756-01) under gentle rotation overnight, at 4°C and washed 
3-4 x with PBSEEG. The resin was poured into a 10 ml polypropylene column 
(Thermo scientific N°2994), washed with 10 bed volumes of thrombin 
cleavage buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 2.5 mM CaCl2, 0.1 % 
β-mercaptoethanol) at room temperature. 200 Units of thrombin (Sigma T-
1063, 1000 U, dissolved in 0.5 ml thrombin cleavage buffer and 0.5 ml 
glycerol, aliquots had been kept at -20°C) were then added directly onto the 
column, the column was closed on both ends and incubated for 30 minutes at 
room temperature with end over end rotation. A second column with 1 ml p-
aminobenzamidine agarose (Sigma A-8332, 5 ml) was washed with 20 ml 
thrombin cleavage buffer. The glutathione sepharose column was eluted with 
thrombin cleavage buffer directly onto this second column. Fractions of the 
flow-through were collected at the bottom of the second column. Protein 
levels were measured and fractions of interest were pooled. Eluted protein 
was transferred into PS buffer (10 mM PIPES-KOH pH 6.8, 200 mM sorbitol) 
containing 150 mM KCl by repeated dilution and ultrafiltration in Amicon Ultra-
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15 30K (Millipore), finally concentrated to 3 mg/ml, aliquoted, flash-frozen in 
liquid nitrogen and kept at -20°C. 
 
Purification of HOPS, HOPS subcomplexes and CORVET 
These complexes were purified via the TAP protocol, as previously described 
(Ostrowicz, Brocker et al., 2010). In brief, yeast cell lysates were prepared 
from 500 OD600 equivalents of cells by thoroughly vortexing cells in lysis buffer 
[50 mM HEPES/KOH, pH 7.4, 300 mM NaCl, 0.15% NP-40 (Igepal CA-630; 
Sigma-Aldrich), 2 mM MgCl2, 1 mM DTT, 1 mM phenylmethylsulphonyl 
fluoride (PMSF) and 1xFY protease inhibitor mix (Serva)] together with glass 
beads in a Disrupter Genie for 10 min at 2°C, followed by centrifugation at 
20'000 xg at 4°C. The supernatant was centrifuged for 60 min at 100'000 xg 
and the cleared lysate loaded onto 25 μl of prewashed IgG beads. After 1 h of 
incubation at 4°C, the beads were washed 3 times with 1 ml lysis buffer 
containing 0.5 mM DTT, but lacking protease inhibitors. Bound proteins were 
eluted by TEV protease treatment for 1 h at 16°C. TEV eluates were either 
analyzed by SDS–PAGE and Coomassie staining or loaded onto 25 μl of 
prewashed calmodulin–sepharose beads, and incubated for 1 h at 4°C. The 
beads were washed 3 times with 1 ml lysis buffer, bound proteins were eluted 
by incubation with 20 mM EGTA in lysis buffer for 20 min at 30°C, analyzed 
by SDS–PAGE and Coomassie staining and kept in small aliquots at -20°C. . 
Aliquots were thawed and the proteins transferred into lysis buffer without 
DTT and NP-40 by repeated dilution and ultrafiltration (4°C) in Amicon Ultra-
15 30K (Millipore). Re-concentrated proteins were used immediately for the 
experiment and not re-frozen. 
 
Rapamycin-induced protein re-localisation 
Cells were grown in YPD over night at 30°C to early logarithmic phase. Cells 
were diluted to OD600=0.2 for staining with 5 µM FM4-64 and then incubated 
with rapamycin (10 µM) before image acquisition.  
 
Statistics for biological experiments 
When data was averaged, the samples stem from independent experiments 
with independent preparations of vacuoles or cells, i.e. they represent 
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biological replicates. The number of replicates is indicated in all figures as n, 
the variation of their values is characterized by the standard deviation (s. d.). 
Significance of differences has been evaluated through Student's t-test. 
Differences are only mentioned as such and interpreted if p<0.005. 
 
 
Molecular dynamics 
 
Simulation model and settings  
The molecular dynamics simulations were performed with the GROMACS 
simulation package 37, version 4.5.7. We used the MARTINI coarse-grained 
model 38,39 to simulate the lipids, amino acids and solvent. In all simulations, 
the system was coupled to a constant temperature bath using the 'V-rescale' 
algorithm with a relaxation time of 1.0 ps. All simulations were performed at a 
temperature of 293 K. Periodic boundary conditions where applied to simulate 
bulk behavior. The time step used in the simulation was 20 fs. The dielectric 
constant in the simulations was εr = 15. The neighbor-list was updated every 
10 simulation steps. The pressure was weakly coupled 40 to 1 bar with a 
relaxation time of 1.0 ps. Here, only the z-dimension was independently 
coupled to the pressure bath because the x and y-dimension of the simulation 
box were conserved (see Membrane simulation setups).  
 
Modeling the vacuolar SNARE complex 
The vacuole SNARE complex was modeled using the MARTINI model for 
proteins 38, which qualitatively captures the chemical nature of each individual 
amino acid and includes the secondary structure. For NYV1 the modeled 
sequence is 
“IGDATEDQIKDVIQIMNDNIDKFLERQERVSLLVDKTSQLNSSSNKFRRKAV
NIKEIMWW[QKVKN]ITLLTFTIILFVSAAFMFFYLW”, for VAM3: 
“TIIHQERSQQIGRI 
HTAVQEVNAIFHQLGSLVKEQGEQVTTIDENISHLHDNMQNANKQLTRA[DQ
HQRDRNK]CGKVTLIIIIVVCMVVLLAVLS”,  for VTI1: 
“IDDDQRQQLLSNHAILQKSG 
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DRLKDASRIANETEGIGSQIMMDLRSQRETLENARQTLFQADSYVDKSIKTL
KTMTR[RLVANK]FISYAIIAVLILLILLVLFSKFK”, and for VAM7 
“MQMVRDQEQELV 
ALHRIIQAQRGLALEMNEELQTQNELLTALEDDVDNTGRRLQIANKKARHF”. 
Here, the brackets  [] depict the defined juxta-membrane (linker) regions. The 
resolved and previously simulated structure 40 of the neuronal SNARE 
complex was used as a template structure for the vacuolar  SNARE complex. 
To this aim, we applied an external field, using a self-modified version of 
Gromacs, to drive the structure of the vacuole SNARE complex toward the 
known structure of the neuronal SNARE complex based on the known 
alignment. All residues are defined alpha-helical except for the defined 
SNARE linkers. The linkers are either modeled as a random coil '~' (in case of 
unstructured) or alpha helical 'H' (in case of structured). We modeled all of the 
three SNARE linkers as being structured because such a scenario maximizes 
the force which a partly-assembled SNARE complex, by itself, can exert on 
the formed stalk. 
 
Membrane simulation setups 
In total three different ‘HOPS’ systems were simulated: 
(1) A system with 3 SNARE complexes (10'158 POPC, 6'771 POPE, 663'000 
water molecules, dimension 48x64x37 nm3, teq=1µs), used in Fig. 4b and 
Extended Data Fig. 8); 
(2) A system with 1 SNARE complex (10'983 POPC, 400'000 water molecules, 
dimension 48x40x33 nm3, teq=1µs), used in Fig. 4a, Extended Data Figs. 9b, 
10); 
(3) A system with 1 SNARE complex (13'621 POPC, 500'000 water molecules, 
dimension 67x40x40 nm3, teq=2µs), used in Fig. 4a, Extended Data Fig. 9b). 
For studying the fusion pore, the system was made slightly larger in order to 
avoid a too close distance between the fusion pore and the free membrane 
edges (see the description below). 
 
It is important to emphasize that the two opposing membranes must be able 
to freely adopt their (local) separation distance in order to realistically mimic a 
scenario where two vacuoles fuse. To this aim, we cut the periodicity of the 
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membrane along the x-dimension (thus preventing that solvent is 'trapped' in 
the space between the two opposing leaflets). The latter creates four free 
membrane edges (e.g., see Extended Data Fig. 8) which facilitate rapid flip-
flop between the leaflets and thereby ensure that the spontaneous curvature 
of the membrane vanishes when the membrane is bent (preventing finite size 
effects). Furthermore, the ability to freely adapt the area of the membrane 
ensures that the membrane minimizes its shape under tension-less conditions 
in the presence of HOPS and thus the work performed by HOPS is only 
determined by membrane bending energy. Finally, to prevent that the large 
line tension of the free membrane edges would strongly deform the simulation 
box (it prefers to minimize the y-dimension while maximizing the x-dimension) 
the x- and y dimension of the simulation box were kept constant. Hence, 
pressure coupling along these dimensions is redundant for a membrane cut in 
one dimension because the membrane area can independently adjust with 
respect to the (corresponding) area of the simulation box (the system is 
isotropic). 
 
Model and setup of the HOPS simulations 
In our simulations, 'soluble' HOPS is modeled by a soft harmonic repulsive 
potential (Kforce = 50 kJ nm-2mol-1). The 'attractive' HOPS is modeled by the 
potential function, V(d)=Kforced2(d2-C), where V(d) is the potential energy as a 
function of the penetration depth d, i.e. the distance beyond the surface of 
'HOPS'. Here, Kforce and C (the width of the well) are set to  Kforce = 20 kJ nm-
2mol-1  and  C=0.4 nm2. Because the additional presence of attractions 
reduces the apparent radius of HOPS we compensated for this by slightly 
increasing its radius (7.4 nm versus 7.0 nm). The 'HOPS' potential only acted 
on the carbon tails and glycerol parts of the lipids. To mimic a SNARE 
complex which is slightly embedded by HOPS  11 we modeled a slight overlap 
between HOPS and the SNARE complex, i.e. the SNARE complex is located 
within HOPS about 2 nm away from its surface (see Extended Data Figs. 
8/10). In reality, the depletion of solvent interactions upon binding will be 
compensated by competitive interactions with the binding pocket of HOPS. In 
our model, solvent was allowed to freely enter and pass  'HOPS'  in order to 
conserve ongoing interactions within the coiled-coil complex of the SNAREs. 
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The main advantage of modeling HOPS by an effective potential is that this 
allows direct quantification of the work which HOPS must perform to conserve 
the corresponding membrane shape of minimal free energy. The HOPS 
simulations were setup via the slow growth method, i.e., the radius of HOPS 
was gradually increased from 0 to the target radius over 80ns. During this 
procedure, the SNARE complex was restrained by restraining only a single 
bead within the SNARE complex (the backbone bead of residue GLY218 
within VAM3) via a harmonic potential (Kforce = 1000 kJ nm-2 mol-1).  After 
equilibrium was reached – equilibrium was characterized by the pressure 
(bending work) and the resultant force on HOPS - we restrained 15 additional 
backbone atoms within VAM3 (GLY218 - ASP232) to simulate a torsional 
restraining effect of the binding pocket on the SNARE complex. 
Finally, the stalk in all of the setups is generated by applying an external field. 
Here, we applied a harmonic potential (50 kJ nm-2 mol-1) to induce a 
cylindrically shaped 'void' of 1.0 nm radius in the solvent layer between the 
bilayers. The hydrophobic nature of the void attracts the lipid tails in the 
adjacent leaflets and results in the formation of a stalk. Notable, this whole 
process occurs on a timescale of a few nanoseconds only. The external 
potential is removed prior to subsequent equilibration and introduction of the 
HOPS sphere. 
 
Free energy of fusion and SNARE forces 
We performed two different types of so-called umbrella sampling protocols 
with different goals:  
(A) How does HOPS binding affect the free energy landscape of fusion pore 
opening? To this end, we used simulation system 1 (see above) with probe to 
probe distance (stalk thickness) as a reaction coordinate. 
(B) How does HOPS binding affect the force that the bound SNARE complex 
exerts on a fusion intermediate. To this end, we used simulation system 2 
(see above) with the distance between the C-termini of Nyv1 and Vam3 as a 
reaction coordinate. 
 
In protocol A, we pull two hydrophilic 'beads' (probes) through the stalk center 
in order to estimate the free energy required to open the fusion pore. Each 
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probe is comprised of 8 clustered solvent beads. The “stalk thickness” is 
defined by the distance between the two probes. The rationale is to bring the 
system close to the nucleation barrier until that barrier can be crossed 
spontaneously within the simulation time scales. The work required to enforce 
nucleation provides an estimate of the height of the barrier. For more detailed 
information see our previous work 32. 
 
In protocol B, we study how HOPS binding alters the force that the C-termini 
of Nyv1 and Vam3 exert on the stalk intermediate. We rationalize such an 
effect from the relative change in work required to slightly pull the SNARE C-
termini (Nyv1 and Vam3) in closer proximity in the presence or absence of 
HOPS. Slightly implies that we only indent/squeeze the stalk such that the 
stalk will recover if no active pulling force is applied anymore 
(thermodynamically reversible).   
 
To derive the associated free energies in both of these protocols, we applied 
umbrella simulation techniques (Kforce = 1000 kJ nm-2mol-1) in combination 
with the weighted histogram method. We generated independent states along 
the reaction coordinate (50 for protocol A, 15 for protocol B) by performing a 
stirred molecular dynamics simulation over the entire reaction coordinate (pull 
rate: -5x10-5 nm/ps) in a pre-equilibrated system. Equilibrium was 
characterized by the pressure (bending work) and the resultant force on 
HOPS. For protocol A, a separate, independent stirred MD run must be 
performed for each different system (e.g., the attractive HOPS case) because 
the generated states will embed information about the nature of the barrier. 
The umbrella simulations were performed after the systems were equilibrated 
for ~1.6 us, i.e., the last snapshot was used for a stirred MD simulation, from 
which the different umbrella windows were generated. Equilibrium was 
characterized by the pressure (bending work) and the resultant force on 
HOPS. Each umbrella window was simulated over an effective time of 400-
600 ns to obtain overlapping distributions from which the total free energy 
profile was constructed. We discarded the first 40 ns of the simulation to 
ensure equilibration of the measured biased force. All of the free energy 
profiles and the error bars herein were obtained by using the Weighted 
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Histogram Analysis Method (WHAM) in combination with the Bayesian 
bootstrapping method41. The bootstrapping method exploits the WHAM 
equations to reconstruct a large multiple of free energy profiles from re-
sampled bootstrap histograms. The errors within the final free energy profile 
are estimated from the statistical fluctuations herein. Each re-sampled 
histogram of the biased force is reconstructed from the data which comprise 
the original histogram (an umbrella window) by random selection with 
replacement. This resampling procedure respects the (on the fly estimated) 
integrated autocorrelation time within the biasing force and adds an additional 
random weight to the histogram within the WHAM equations (Bayesian 
bootstrapping). An excellent detailed description of this procedure has been 
given41. 
 
Bending energy and force 
The bending work is estimated from the total (equilibrium) force that the 
membrane exerts on the surface of HOPS after it adopts its shape of minimal 
free energy. The work (Weq) that HOPS must perform to bend the membrane 
is given by the relationship Weq=1/3 Σfeq,av•r, where  Σfeq,av is the total average 
force that acts on the surface of the HOPS sphere during growth from radius 
r=0 to r=r.  Our continuum elastic calculations revealed that Σfeq  rather 
linearly increases with r. Therefore, we approximated Σfeq,av from r=0 to r=r by 
1/2Σfeq  at r=r. This linear approximation enables (instantaneous) calculation 
of Weq  by averaging over a single simulation (at r=r). For a purely repulsive 
sphere these relationships approximate the concomitant bending energy of 
the adopted membrane shape. We expect, however, to slightly systematically 
overestimate the bending energy (by a few kBT) since the force on the HOPS 
sphere will in reality vanish slightly before r=0 (r ≈0.5 nm). This is due to the 
approximately 1.0 nm inter-membrane separation resulting from the presence 
of the stalk. Notable, HOPS bends the membrane by actively pressing against 
the membrane surface (indentation). This additional stress term (e.g., thinning 
of the membrane) is omitted within the Hamiltonian of the continuum model 
but is not expected to largely contribute to the surface free energy. The 
peristaltic force (fd) on HOPS (see Extended Data Fig. 9) is calculated from 
projecting the resultant force on HOPS (a 3-vector) on the vector connecting 
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the center of HOPS with the stalk center. Here, the stalk center is defined as 
the geometrical center between the C-terminus of NYV1 and VAM3. Finally, 
the average values of bending work and fd are obtained by averaging over 1 - 
2 μs equilibrium simulations. The error in the average value is obtained by 
block averaging. 
 
Continuum model 
Continuum models were performed by minimizing the Helfrich hamiltonian 
within the de Monge representation z(x,y) subjected to two constraints: (i) The 
inter-membrane constraint (a stalk or partly-assembled SNARE complex) and, 
(ii) a solid sphere (HOPS). The membrane was described by a discretized 
sheet consisting of 100 grid elements in the y, and 200 in the x dimension. For 
reasons of symmetry we only model a quarter of the actual system and 
recover the full surface free energy by multiplication with a factor of 4 (for the 
projected area by a factor of 2). Reflecting boundary conditions were used in 
the y-dimension (the symmetry axis), periodic in the x-dimension. The actual 
membrane contact surface in vacuole fusion is of microscopic dimension 42-44, 
indicating that a large multiple of constraints must be present and that the 
membrane is not 'free standing' even over large distances. All dimensions are 
based on the positions of the C4 lipid tail beads (the mid-plane of the 
membrane) within the MD simulations. Finally, HOPS embeds the SNARE 
complex non-symmetrically 11 and will therefore induce torque. Torque (a 
three body force) does not occur when the distance (d) between the center of 
HOPS and the stalk (the two constraints) is used as a reaction coordinate but 
can be additionally derived/constructed by scaling the here-presented force 
(fd) with a sin(θ) term.    
 
The Hamiltonian for each surface element, Ftotal, is given by Fbending + Fconstraint 
+ FHOPS, with Fbending being the Helfrich bending energy,  Fconstraint the energy of 
the inter-membrane constraint (a stalk, fusion pore or partly-assembled 
SNARE complex) and FHOPS the energy of the HOPS' sphere. Fbending is given 
by 2κH2 with H being the mean curvature, and κ the bending modulus (24 kBT, 
see citation 9.).  The constraint Fconstraint is modeled by a set of stiff springs 
which restraints the membrane at a height of zequ = 2 nm and which imposes 
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a circular 'stalk' region with a radius of dstalk=2 nm. Fconstraint depends on the 
distance d between a surface element and the center of the 'stalk' region, and 
the height of the membrane z. Fconstraint =  0 if d > 2 nm and 1/2kstalk (z-zeq)2(d-
dstalk) otherwise, with kstalk being the force constant  
(kstalk =100 kBT/nm5). Here, the term (d-dstalk) ensures a smooth (differentiable) 
transition of the 'stalk' region. HOPS was modeled as a sphere with a 
diameter DH. The center of the sphere is located within the x,y plane at z=0. 
Surface elements overlapping with the HOPS sphere experience an harmonic 
repulsion, FHOPS=1/2kHOPS(2r-DH)2 if 2r<DH  and FHOPS=0 otherwise, with r 
being the distance of a surface element from the center of the sphere. The 
force constant kHOPS was chosen to be 100 kBT/nm4. The example of a 
(moderately) attractive HOPS was modeled using FHOPS=KHOPSd2(d2-C) with 
C=0.5 nm2, and KHOPS = 20  kBT/nm6. Finally, the total surface free energy  
ΣFtotaldA was minimized using an over-damped deterministic minimization 
scheme. We emphasize that the values predicted by the continuum model are 
subject to simplification of the characteristics of the system (e.g. exact spatial 
dimensions, and the nature of the inter-membrane restraint). They also rely on 
the estimation of the  bending modulus of the membrane. 
 
Code availability 
The molecular dynamics simulations were performed with a self-modified 
version of the open source software Gromacs-4.5.5. The implementation of 
the here-used HOPS potentials is described in detail in the supplement. The 
code is publically available under http://nlor.theorie.physik.uni-
goettingen.de/~hrissel/code/ 
 
 
Data availability 
All original data will be made available by the authors upon request. 
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Extended Data Figure Legends: 
 
Extended Data Fig. 1: Reagents. 
a, HOPS is lacking on ypt7D vacuoles. HOPS and Ypt7 content of total cell 
extracts and purified vacuoles from wildtype and ypt7D mutants in BJ3505 
and DKY6281 cells, representing the background strains used for the content 
mixing assay. b, Purified HOPS, HOPS subcomplexes and CORVET. The 
complexes used for the in vitro experiments were analyzed by SDS-PAGE 
and Coomassie staining. The gel represents the preparations, which followed 
published routine procedure, used for the experiments in Fig. 1 and Extended 
Data Figs. 3 and 4. c, Production of Fab fragments from polyclonal antibodies 
to Vam3 and Nyv1. Schematic view of papain cleavage sites for Fab fragment 
generation on the left. Affinity-purified antibodies and Fab fragments extracted 
after papain digestion were analyzed by non-reducing SDS-PAGE and 
Coomassie staining. The gel shows the preparation used in Fig. 2. d, 
Expression of FKBP and FRB fusion proteins. Total cell extracts were 
prepared from 0.1 OD600nm units of logarithmic cultures of  yeast strains 
expressing Vam7-2xFKBP12 and/or Pfk1-FRB-GFP. Proteins were analyzed 
by SDS-PAGE and Western Blotting against Vam7, Vam3 and GFP. e, Same 
as in d, but for cells expressing Vam7-LL-2xFKBP12, containing the 35 aa 
linker (LL). For a and c-e, similar results were obtained from two independent 
preparations.  
 
 
Extended Data Fig. 2: Kinetics and efficiency of in vitro vacuole fusion, 
measured by content mixing. 
Vacuoles are prepared from two different strains, which contain either the 
soluble 45 kDa maturase Pep4 (contained in DKY6281) or the pro-alkaline 
phosphatase p-ALP (contained in BJ3505). Formation of a sufficiently large 
fusion pore allows Pep4 to transfer into the p-ALP containing fusion partner, 
leading to proteolytic cleavage of its pro-sequence and activation of the 
enzyme (m-ALP). This activity is measured as a readout for fusion. Note that 
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proteolytic maturation of p-ALP is fast and not limiting for the development of 
the content mixing signal 45. Standard fusion reactions have been started. At 
the indicated time points, aliquots were withdrawn and set on ice. a, At the 
end of the 60 min period, m-ALP activity was determined for all samples. 
Means ± s.d. are shown for n=3 biologically independent experiments. b, 
Aliquots from one of the experiments in (a) were TCA-precipitated and 
analyzed by SDS-PAGE and Western blotting against ALP and Vam3. Signals 
were detected on a LICOR infrared scanner (left) and quantified (right) as the 
ratio m-ALP / (m-ALP + p-ALP). Vam3 has been decorated as a loading 
control. Note that after one round of fusion, only a maximum of 50% of p-ALP 
can be matured, because half of the fusion events in the suspension will occur 
between like vacuoles (i.e. Pep4/Pep4 or p-ALP/p-ALP) and will not produce a 
signal. 
 
 
Extended Data Fig. 3: HOPS and CORVET complexes stimulate fusion to 
similar degrees. 
Two-stage fusion reactions with ypt7D vacuoles were run as in Fig. 1g, in the 
absence of ATP. rVam7 had been added in the first phase of the incubation, 
0.4µM HOPS subcomplexes or 0.4µM CORVET only in the second. Half of 
the samples received an addition of 6% of Ficoll 400 in the second incubation, 
an agent mimicking molecular crowding 35. At the end of the 75 min incubation 
period, content mixing was assayed. Fusion activity of a standard wildtype 
reaction performed in the presence of ATP served as 100% reference. Means 
± s.d. are shown for n=3 biologically independent experiments. 
 
 
Extended Data Fig. 4: ypt7D vacuoles require both Vam7 and HOPS for 
content mixing. 
Two-stage fusion reactions were run as in Fig. 1g in the presence or absence 
of ATP. rVam7 had been added in the first (Io) phase of the incubation, HOPS 
only in the second (IIo). At the end of the 75 min incubation period, content 
mixing was assayed. Means ± s.d. are shown for n=3 biologically independent 
experiments. 
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Extended Data Fig. 5: A molecular crowding agent cannot stimulate 
fusion in the absence of bulky SNARE ligands.  
Two-stage fusion reactions with ypt7D vacuoles were run as in Fig. 2b, in the 
absence or presence of ATP. rVam7 had been added in the first phase of the 
incubation where indicated, antibodies and various concentrations of the 
crowding agent Ficoll 400 only in the second. At the end of the 75 min 
incubation period, content mixing was assayed. Fusion activity of a wildtype 
reaction performed in the presence of ATP served as 100% reference. Means 
± s.d. are shown for n=3 biologically independent experiments. 
 
 
Extended Data Fig. 6: Effect of rapamycin-induced dimerization on in-
vivo vacuole fusion using the small fusion protein FRB-GFP. 
a, Schematic view of rapamycin-induced FKBP12/FRB-tagged protein 
dimerization between Vam7-2xFKBP12 and FRB-GFP. b, Logarithmically 
growing cells, expressing tagged Vam7-2xFKBP12, were stained with the 
vacuole tracer FM4-64 and analyzed by spinning disc microscopy before and 
10 min after the addition of 10 µM rapamycin. Scale bar: 5 µm. Similar results 
were obtained in 3 biologically independent repetitions. 
 
 
Extended Data Fig. 7: Fusion can be prematurely triggered by protein 
recruitment after osmotically induced vacuole fragmentation. 
a, Logarithmically growing cells, carrying Vam7-2xFKBP12 and Pfk1-FRB-
GFP as indicated, were stained with the vacuole tracer FM4-64. Vacuole 
fission was induced by adding 0.5 M NaCl. Cells were analyzed by spinning 
disc microscopy before and 10 and 60 min after salt addition. The cells were 
grouped into three categories according to the number of vacuoles visible per 
cell. 100 cells were analyzed per sample. Values represent the means and s.d. 
from n=3 biologically independent experiments. Scale bar: 5 µm. b, As in a, 
but 10 µM rapamycin was added before the salt shock. c, As in b, but with 
cells expressing non-tagged Vam7. 
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Extended Data Fig. 8: Effect of HOPS on the free energy barrier of fusion 
pore formation. This plot complements Fig. 4 in the main manuscript.  
a. The free energy barrier of fusion pore opening is derived for a simulated 
system consisting of 3 SNARE complexes (panels on the right side) and a 
POPC membrane that contains 40% POPE (colored orange). To this aim, we 
pull two hydrophilic probes (colored purple) towards the center of the stalk 
and estimate the work (ΔG) as a function of probe – probe distance (the stalk 
thickness)32. The arrows in the free energy profile indicate the nucleation 
barrier for the fusion pore. Beyond this stage, subsequent pore opening 
proceeds in the absence of additional work (the plateau region). Tethering 
proteins such as HOPS are attracted to the membrane through Rab-GTPases 
or direct lipid interaction10,46. An attractive 'HOPS' surface (green line) 
conserves the lowered nucleation barrier, even when the surface attractions 
fully compensate the membrane bending energy (no net bending work; 
Extended Data Fig. 9). Error bars are calculated via Bayesian resampling of 
50 overlapping WHAM histograms [43]. Each parental WHAM histogram is 
comprised of  >30000 data points (autocorrelation up to ~1500 data points).  b,  
Pore formation in the absence of HOPS. A defect is frequently formed in the 
vicinity of the SNARE TMDs (black arrow), illustrating the presence of a high 
stress (the defect likely decreases the bending stress). Fusion pore formation 
is associated with a sudden reduction of the sharp curvature near the stalk's 
circumference (dashed lines). Fusion pores tend to adopt a teardrop shape 
47,48. c, Fusion pore formation in the presence of HOPS. The pre-existing 
teardrop membrane shape imposed by HOPS likely provides a geometrical 
and therefore an energetic advantage for pore formation. d,  Setup where we 
artificially enforced formation of a leakage pore/defect in the direct vicinity of 
the stalk (the rationale behind this has been explained 32). The induced defect 
(Between 3.2 and 1.8 nm the probe pierced through the membrane) 
instantaneously recovers. This suggests that the stress that HOPS imposes 
on the fusion site does not poise fusion to become leaky.  
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Extended Data Fig. 9: Detailed analysis of HOPS-mediated membrane 
bending in the presence of an inter-membrane restraint.  
a, Simulation snapshot illustrating the geometry of the system. Shown is the 
central plane of the membrane (the lipid tail ends), the stalk, and HOPS. The 
SNARE complex present in the simulation setup is not illustrated. This setup 
serves as a motivation for the elastic continuum model. b, Bending work 
required to place HOPS at the (hemi-)fusion site and peristaltic force 
experienced by HOPS. Simulations were run to measure the work required to 
place HOPS-like spheres of 10-14 nm diameter at the site of hemifusion or at 
a fusion pore (FP). HOPS could be detached from the SNARE complex by a 
long spacer (link.). The influence of a SNARE complex with an unstructured, 
non-helical juxta-membrane region (unstr.) and of a HOPS mimic that was 
attractive to the membrane surface (attr.) was also analyzed. The lower panel 
shows averages obtained from the simulations. fd is the (peristaltic) force that 
pushes HOPS away from the inter-membrane restraint (e.g., a stalk, fusion 
pore, or trans-SNARE complex). Note that surface attractions or Rab-GTPase 
interactions of HOPS (modeling the tethering of membranes) 10,46 can yield a 
negative value of the average work required to bend the membrane (bending 
occurs spontaneously). Fusion pore formation reduces the required bending 
work – it moves HOPS away from the restraint because of additional SNARE 
association up into the TMD region. The errors in the averages are derived 
from block averaging over >10000 data points until the error becomes 
independent of block size (autocorrelation up to ~300 data points). The errors 
in the averages are derived from block averaging over >10'000 data points 
until the error becomes independent of block size (autocorrelation up to ~300 
data points).  c, Elastic continuum model. The coordinate system is based on 
the snapshot of the molecular dynamics simulation shown in panel a. 
Because of symmetry along the xy-plane and xz-plane, we only model a 
quarter of the original system. The cartoon illustrates the shape of minimal 
free energy for a membrane (modeled by a single sheet), subjected to two 
constraints: (i)  A local constraint on the position (height) of the membrane 
illustrated by the black arrow at z=2 nm. This mimics the inter-membrane 
constraint (stalk, fusion pore or partly-assembled SNARE complex), (ii) The 
presence of a hemisphere. This mimics HOPS. The color code illustrates the 
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height of the membrane (the z-axis) relative to the two constraints. d, 
Prediction of bending energies by the elastic continuum model. The bending 
energy is shown as a function of the size and distance of HOPS to the inter-
membrane restraint. Upper panel: Bending energy decreases steeply when 
HOPS moves away from the restraint. The predicted values are about a factor 
of two lower than the “bending work” predicted by the simulations (see 
Methods). Middle panel: the corresponding peristaltic force fd on HOPS (the 
derivative of bending energy). At short distances, fd becomes substantial (tens 
of pN). Note that making the surface of HOPS moderately attractive to the 
membrane affects fd only weakly, i.e. it does not result in an attraction towards 
the 'stalk'. Lowest panel: The relative reduction of membrane area as a result 
of HOPS-induced membrane bending. This property reflects the tension that 
HOPS induces by curving the membrane near the contact zone. In contrast to 
bending energy and force, tension only weakly depends on the distance (d) to 
the restraint.  
 
Extended Data Fig. 10: Effect of HOPS on the force exerted by a single 
SNARE complex.  
a, One way of rationalizing the acceleration of fusion pore formation by a 
SNARE complex is to consider it as a mechanical device that exerts force on 
the luminal leaflets through its TMDs, thereby compressing the stalk. This can 
happen through a peristaltic force that pulls the SNARE complex away from 
the stalk, or through the elastic bending of the SNAREs. This latter mode of 
force transmission requires the juxta-membrane regions, which connect the 
coiled-coil domains of the SNAREs to their TMDs, to be structured and rigid. 
The compressing force that the SNARE complex exerts on the stalk can be 
rationalized from the apparent work (free energy) that one needs to perform in 
order to force the luminal C-termini of Vam3 and Nyv1 in closer proximity. We 
estimated how HOPS binding affects the force that the C-termini of the 
SNAREs Vam3 and Nyv1 exert on the stalk. b, The work required to slightly 
indent the stalk in the presence of repulsive or attractive HOPS-spheres of 
different diameter has been determined. It is shown relative to the situation 
without the sphere. Error bars are calculated via Bayesian resampling of 15 
 35 
overlapping WHAM histograms 41. Each parental WHAM histogram is 
comprised of  >30'000 data points (autocorrelation up to ~1200 data points). 
The lines shown result from fitting a power expansion (up to the 4th power) 
through the average of each data point. Error bars are calculated via 
Bayesian resampling of 15 overlapping WHAM histograms [43]. Each parental 
WHAM histogram is comprised of  >30'000 data points (autocorrelation up to 
~1200 data points). The lines shown result from fitting a power expansion (up 
to the 4th power) through the average of each data point. c, The 
corresponding forces on the SNARE TMDs were derived from this work. 
Apparent gains in the force exerted by the SNARE C-termini (left panel) are 
shown as a function of their distance in the hemifusion structure. HOPS 
binding can double or triple the magnitude of the apparent force (10-20 pN) 
that a SNARE complex exerts on a stalk 49. The gain dissipates, however, as 
zipping of the SNARE TMDs progresses and their C-termini approach each 
other. d, Snapshots of three special scenarios. Highest panel: The HOPS 
sphere is placed at a distal location with respect to the stalk (e.g., via 
attachment with a flexible linker). This abolishes the force gain. Middle panel: 
A sphere that favorably attracts (and bends) the membrane. This conserves 
the force gain. Lowest panel: Unstructured, flexible SNARE juxta-membrane 
regions partially disrupt the mechanical coupling between the coiled-coil 
domains and the TMDs. They decrease the apparent gain in SNARE pull 
force induced by HOPS. Structured (a-helical) SNARE juxta-membrane 
regions result in a high initial force gain which gradually reduces. In contrast, 
unstructured, flexible juxta-membrane regions, which impair vacuole fusion 50, 
result in a near-constant force gain of only about 8 pN. Both cases converge 
to similar force values when the C-termini of Vam3 and Nyv1 come in closer 
proximity. Since the SNARE complex is unable to exert bending force on the 
membrane when the connection between its transmembrane anchors and the 
SNARE domains is completely flexible, we relate the remaining gain to an 
effective 'softening' of the stalk because of the induced membrane curvature 
and to the peristaltic force generated by the interaction of the HOPS sphere 
with the SNAREs. 
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Supplementary Discussion: How do SNARE ligands enhance opening of the 
fusion pore? 
 
Membrane curvature as a driving force 
HOPS appears to contribute two separable functions to vacuole fusion. It catalyzes 
SNARE complex assembly 1-4, which is necessary for membrane docking and the 
induction of hemifusion. However, it also binds to the assembled SNARE complex 5 
and, as we show here, this interaction promotes the formation or expansion of the 
fusion pore. This second function can explain why Vps33 with amino acid 
substitutions can support normal trans-SNARE pairing and lipid mixing but not 
content mixing6. It is also compatible with subsequent studies on liposome fusion, 
which found that the addition of the Vps33-containing HOPS complex not only 
increased SNARE complex formation several-fold, but also led to a 
disproportionately higher increase in content mixing 7. While there is a priori no 
reason to assume that SNARE complex density should be linearly related to the rate 
of content mixing, this result is consistent with the steric effects of HOPS on the 
fusion site that we describe here.  
 
Another unexplained finding is that SNARE ligands such as Sec17/a-SNAP and 
Sec18/NSF, which are normally involved in SNARE complex disassembly, can 
stimulate liposome fusion under certain conditions8. They are particularly effective 
when used in conjunction with a non-hydrolysable ATP-analog, which stabilizes 
SNARE/a-SNAP/NSF complexes 9. Also the fusion of intact vacuoles can be 
stimulated by Sec17/a-SNAP, but only if complete SNARE complex zippering is 
prevented by a C-terminal truncation of the Qc-SNARE Vam7 10. On vacuoles with 
wildtype SNAREs, release of Sec17 from the membrane is necessary for fusion 11 
and addition of Sec17 is even inhibitory 12. It has been argued that binding of Sec17 
might stimulate fusion by stabilizing or ordering incompletely zippered SNAREs 10. 
This raises the question whether binding of HOPS or of SNARE antibodies might 
promote fusion by favoring the transition from partially zippered to fully zippered 
SNARE complexes. We consider this as unlikely for several reasons. First, full 
zippering of SNAREs is necessary to efficiently reach lipid mixing 10. Since vacuoles 
reach a hemifused state in our experiments, we can expect them to have zippered 
SNARE complexes. Second, HOPS binds SNARE complexes through Vps33 and in 
our experiments Vps33 alone acts as a competitive inhibitor of fusion (Figs. 1,2). But 
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when the effective size of Vps33 is increased by addition of monoclonal antibodies to 
a C-terminal peptide tag of this protein, fusion is strongly stimulated. Since this 
monoclonal antibody does not recognize the SNAREs, it is difficult to conceive how it 
might have a structuring or ordering effect on partially zippered SNARE complexes. 
Third, in vivo vacuole fusion can be triggered by recruiting the bulky 
phosphofructokinase to the SNARE complex, which is completely unrelated to fusion 
and unlikely to undergo any direct interaction with SNAREs. Thus, stimulation by a 
simple increase in SNARE complex volume remains the most suitable interpretation.  
By analogy, we propose that also Sec17/a-SNAP and Sec18/NSF, of which several 
units can bind the SNARE complex at a time 13, stimulate liposome fusion by acting 
as bulky ligands that deform the fusion site. This model is also consistent with the 
observation that the membrane-intercalating sequences of Sec17/a-SNAP are 
dispensable for fusion as long as full-length, wildtype SNAREs are used 9. 
 
Since we can stimulate the transition from hemifusion to full fusion by bulky SNARE 
ligands, the SNARE domains must be sterically accessible in these intermediates. 
We posit that the hemifusion zone behaves like a Brownian ratchet. Spontaneous 
shape fluctuations of the apposed membranes might liberate the space for bulky 
SNARE ligands, which, once bound, fix the system in this spontaneously created, 
highly curved or "tense" state. Thereby, they will increase the probability of pore 
opening or expansion relative to the "relaxed" state, in which fluctuations into the 
highly curved state would be short-lived and the probability for pore formation would 
remain low.  
 
Electron microscopy structures of HOPS feature a SNARE-binding domain (head 
region) of approximately 12-14 nm diameter, which probably encapsulates the 
SNARE complex 14,15. Binding this head region to SNAREs will markedly affect the 
geometry of the hemifusion stalk, which restrains the apposed membranes from 
separating and thereby enforces strong local membrane curvature. On first sight, it 
may seem trivial to relate the HOPS-induced high curvature to enhanced fusion 
activity. Inducing curvature-stress is a well-accepted mechanism to accelerate fusion 
16 and small vesicles are more 'fusogenic' than large ones 17.  However, fusion does 
not relax the curvature-stress that HOPS imposes on the two flat membranes in an 
immediately apparent way (Fig. 4a & Extended Data Fig. 8) and other factors, such 
as peristaltic forces and increased pulling on the SNARE transmembrane domains 
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might play major roles. The driving force that HOPS contributes to fusion pore 
opening is thus not obvious – necessitating theory and simulations in order to 
explore its sources.  
   
The energy stored in the imposed membrane curvature 
To gain insights into the bending energy (stress) imposed on the fusion site by the 
HOPS-SNARE complex, we performed both molecular dynamics (MD) simulations 
and elastic continuum modeling (see Methods). Although a recent study reported the 
existence of extended hemifusion diaphragms between yeast vacuoles fusing in vitro 
18, our own studies by light and electron microscopy did not reveal extended 
hemifusion zones at a sufficient frequency to permit their quantification and 
interpretation (D'Agostino and Mayer, in preparation). Therefore, our models assume 
a stalk as the hemifused structure. Our conclusions would not qualitatively change if 
the hemifused structure were a diaphragm. In the MD simulations, we derived the 
work that HOPS must perform to bend the membrane and counteract the (partial) 
pressure that the membrane exerts on the surface of HOPS. In mechanical 
equilibrium, the bending work, which HOPS must perform to conserve the membrane 
shape of minimal free energy, equals the exerted pressure (P) times the volume (V) 
of HOPS. For a purely repulsive sphere this will approximate the bending energy of 
the adopted shape. The elastic continuum model underestimates the actual bending 
work by about a factor of two (see Methods for a detailed explanation). This bending 
energy (equilibrium bending work) amounts to about 75 kBT (12 nm HOPS sphere) to 
115 kBT (14 nm HOPS sphere) (Extended Data Fig. 9b). These values are, however, 
subject to the approximation of shape, the location with respect to the stalk (e.g. 
Extended Data Fig. 9c), and the location within the vacuole-vacuole contact zone (at 
the curved periphery of the contact zone, called the vertex ring 19, these values will 
likely be lower). Since HOPS catalyzes SNARE complex assembly, we expect that a 
substantial fraction of the bending work will be overcome by SNARE complex 
formation (~65 kBT per SNARE complex 20). Furthermore, HOPS tethers membranes 
through Rab-GTPases and direct lipid interaction 21,22. To discern whether the 
acceleration of fusion might rely on the absence or presence of tether activity, we 
additionally modeled a HOPS with tether activity (coined '14 nm HOPS attractive') by 
including weak attractions between the surface of HOPS and the membrane. These 
surface attractions can render the average performed bending work negative (Figure 
S9b; green line). This implies that the bending energy is fully compensated by the 
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favorable surface attraction and that the presence of HOPS will spontaneously curve 
the membrane also in the absence of the stalk. However, these attractions do not 
imply that the bending energy and thus the stress imposed on the adherent 
membranes vanishes (see Fbending  in Extended Data Fig. 9b,d). 
 
The peristaltic force on HOPS 
To gain insight into the force required to restrain HOPS at the fusion site, we 
estimated the peristaltic force fd, which pushes HOPS away from a stalk, a fusion 
pore, or a SNARE complex. It originates from the induced membrane curvature and 
may be enhanced by osmotic pressure of the fusing vesicles. Both our MD 
simulations and the elastic continuum model estimate the curvature-induced 
component of this force to be several 10s of pN, up to 60 pN, when HOPS binds 
close to the fusion site (Extended Data Fig. 9b,d). Intuitively, we expect fd to 
decrease when HOPS is located at the vertex, i.e. at the already curved periphery of 
the vacuole-vacuole contact zone. However, while surface attractions (membrane 
tethering) reduce fd by half in the MD simulations (Extended Data Fig. 9b), they do 
not give rise to a free energy minimum near the constraint, as shown by our 
continuum model (Extended Data Fig. 9d). Therefore, HOPS can only be kept near 
the constraint by binding to the SNARE complex, which counteracts fd.  
 
Influence of HOPS on the pulling force of SNARE transmembrane domains 
Vice versa, HOPS will exert a pulling force on the SNARE C-termini, which are 
thought to approach each other during the progression from hemifusion to pore 
opening until they closely associate as observed in the neuronal SNARE complex 23. 
To estimate to which degree bulky SNARE complex ligands, such as HOPS, may 
alter the force that SNARE TMDs exert on the luminal leaflets (Extended Data Fig. 
10a), we performed coarse-grained molecular dynamics simulations. We rationalized 
the gain in force from the reduction in relative work (ΔΔG) (Extended Data Fig. 10b) 
required to slightly bring the luminal C-termini of Vam3 and Nyv1 into closer 
proximity. The corresponding forces on the SNARE TMDs were derived from this 
relative work (Extended Data Fig. 10c). With slightly we emphasize that the here-
imposed stalk indentation is reversible, meaning that the stalk will recover upon 
removal of the external force (no fusion barrier is being crossed).  
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HOPS reduces the relative work that the SNARE complex must perform to (slightly) 
indent the stalk by up to 12 kBT (Extended Data Fig. 10b). The corresponding 
apparent 'force gain' is given by the derivatives of this work function (Extended Data 
Fig. 10c). Its magnitude of 10-30 pN suggests that HOPS binding would gain the 
equivalent of one SNARE complex 20,24,25. Its magnitude shows a high offset value 
which gradually converges as the C-termini approach each other. In contrast, 
simulations where the juxta-membrane regions between the coiled-coil and 
transmembrane domains were modeled as fully flexible (unstructured) - rendering 
the SNARE complex mechanically ineffective for transmitting bending force to its 
TMDs - showed a lower but constant 'force gain' (8 pN for 14 nm "HOPS", Fig S10c). 
This illustrates that the initial apparent force gain largely depends on the mechanical 
stiffness of the SNARE linkers. It likely originates from a projection of the peristaltic 
force on the SNARE C-termini. This is not necessarily intuitive since the stalk 
imposes an inter-membrane constraint and therefore one might expect that the 
imposed stress tends to stretch the stalk rather than ease its indentation.  
 
The observed force gain is compromised by positioning "HOPS" more distally with 
respect to the stalk (Extended Data Fig. 10b,c; HOPS 12 nm (linker)). This suggests 
that the force gain is mediated by direct steric effects of HOPS on the site of 
hemifusion. Although the force gain is substantial with respect to the inherent force 
exerted by a SNARE complex  – doubling or even tripling the effective SNARE force 
-- the concomitant gain in free energy, i.e., the  driving force of fusion, remains (I) 
relatively small (~10 kBT) and (II) largely relies on the mechanical stiffness and thus 
the adopted secondary structure of the HOPS-bound SNAREs. 
 
HOPS-induced membrane tension 
The curvature induced by HOPS reduces the effective, projected area of the 
proximal leaflets via corrugation of the membrane surface. This may result in a 
concomitant surface tension. It is unclear whether such a (local) tension could relax 
(dissipate) via lipid diffusion, solvent efflux and/or lipid flip-flops (in case of 
asymmetric leaflet tension or spontaneous curvature). We used our continuum 
model to estimate the membrane area (A-A0) that would be required to compensate 
for this tension induced by the presence of HOPS (Extended Data Fig. 9c). A single 
HOPS sphere, which is closely restrained to the fusion site, will reduce the area of 
the membrane-membrane contact zone by ~70 nm2. Although this may in principle 
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generate significant tension at high densities of HOPS on the membrane, we can 
effectively rule out tension as a main cause of accelerated fusion due to our 
experimental observations: Displacing bulky SNARE ligands from the SNARE 
complex via a flexible linker of 35 amino acids abolishes the stimulation of fusion by 
them (Fig. 3). But the required excess membrane area (A-A0), and thereby the 
tension that HOPS might induce, depends only weakly on the distance of HOPS (d) 
from the inter-membrane constraint – quite in contrast to Fbending and fd (Figure 
S9c,d). Therefore, tension should not provide the main driving force for the observed 
acceleration of fusion.  
 
Effect on the free energy barrier of the fusion pore  
We explored the effect of 'HOPS' on the free energy barrier of fusion pore formation 
using a previously published method 26. In order to estimate the free energy required 
to open the fusion pore, we pull two hydrophilic 'beads' (probes; colored purple in 
Extended Data Fig. 8b-d) towards each other near the center of the stalk. Each 
probe is comprised of 8 clustered solvent beads. Bringing the probes in closer 
proximity exerts a squeezing force on the stalk which enforces its expansion 
(evolution). The “stalk thickness” is defined by the distance between the two probes. 
The idea of this approach is that one brings the system close to a nucleation barrier 
until the barrier can be crossed spontaneously within the simulation time scales. The 
work required to enforce nucleation gives an estimate of the height of the barrier. An 
advantage of this approach is that we can use the same reaction coordinate to test 
whether there is a propensity for 'leaky' fusion (coined leakage pore mediated stalk 
elongation 26). For more detailed information see our previous work 26. 
 
The membrane system that we simulated consists of a POPC:POPC mixture (40% 
POPE) with a fusion site comprised of one HOPS-bound SNARE complex and two 
additional unbound SNARE complexes (see Extended Data Fig. 8a and Methods). 
Tension-less membrane conditions are ensured by the presence of free membrane 
edges which allow fast spontaneous lipid flip-flops between the leaflets and free 
adaptation of membrane area. The presence of the HOPS sphere substantially 
reduces the free energy barrier of fusion pore formation, from 67 kBT to 34 kBT 
(Extended Data Fig. 8a). A striking barrier of 67 kBT – despite the presence of three 
SNARE complexes – illustrates how ‘trapped’ the fusion reaction is after stalk 
formation. Furthermore, metastable hemifusion diaphragms, i.e., hemifusion states 
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of the thickness of a single membrane, have not been observed in the simulations, 
suggesting that the stalk to fusion pore transition faces only a single free energy 
barrier. Since HOPS is assumed to tether membranes in vivo 21,22,27, it is important to 
test whether the observed ‘fusion acceleration’ is conserved (if not enhanced) even 
in the presence of membrane tethering, which we have approximated by making 
HOPS membrane-attractive (no net bending work; Extended Data Fig. 9b). This is 
the case. The pronounced reduction of work required to open the fusion pore can 
thus be attributed to a substantial shift in the nucleation barrier towards larger probe 
to probe distances (the arrows in Extended Data Fig. 8a). In other words, opening of 
the fusion pore requires way less squeezing of the stalk – and thus less work – in the 
presence HOPS. This results in a more than 30 kBT decrease of the fusion barrier 
and thereby a dramatic acceleration (>e30) of the subsequent fusion reaction.   
 
Acceleration of fusion pore formation 
Based on the preceding considerations, we propose two possible sources for the 
observed acceleration of fusion pore formation by HOPS:  
 
(I) Relaxation of curvature stress. The progression of SNARE zippering into the 
juxta-membrane and transmembrane domains upon fusion pore opening moves 
HOPS further away from the fusion site – it increases the distance d (Extended Data 
Fig. 9) by about 1 nm. HOPS thereby imposes less of a steric constraint. The 
continuum model illustrates that the bending energy (Fbending) features a sharp, initial 
reduction when a nearby located HOPS complex moves slightly away from the stalk. 
From the MD simulations, we estimate that fusion pore formation reduces the 
bending work that HOPS performs by about 30 kBT. This partial, relative release of 
bending stress may very well drive subsequent fusion pore opening.  
 
(II) Geometrical compatibility. Fusion pore formation involves the formation of 
pronounced ‘wings’ resulting in a teardrop shape 28,29 in order to reduce the 
curvature of the pore interface. A stalk opposes this rearrangement because it forces 
the trans-leaflets to remain largely parallel/horizontal 30. The dashed lines in Figure 
S8b illustrate a fast decrease in curvature upon initial fusion pore opening. Here, the 
pre-existing curvature induced by HOPS (essentially a teardrop shape) is 
geometrically more compatible with a fusion pore than a stalk. This provides a 
relative free energy advantage for fusion pore formation. 
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In the absence of HOPS, the local curvature associated with nucleation of a fusion 
pore in flat membranes is so high that it seemingly becomes advantageous to form 
membrane defects near the transmembrane domains of the SNAREs (Extended 
Data Fig. 8b). Such 'leaky' transitions are not observed in the presence of HOPS, 
probably because it lowers the threshold for fusion pore nucleation and thereby 
channels the reaction towards non-leaky fusion. We have also tested directly 
whether HOPS might render the fusion site prone to membrane rupture. To this end 
we placed the two probes such that pulling them together would locally disrupt the 
membrane near the stalk (see Extended Data Fig. 8d).  Enforcing such a membrane 
defect does not result in membrane rupture but the defect self-heals.  
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Supplementary Tables 
 
Table S1: Yeast strains used in this study 
Strain Genotype Reference 
BJ3505 MATa pep4::HIS3 prb1-Δ 1.6R lys2-208 trp1-Δ 
101 ura3-52 gal2 can 
31 
DKY6281 MATα  pho8::TRP1 leu2-3 leu2-112 lys2-801 
suc2-Δ 9 trp1-Δ 901 ura3-52 
32 
   
BY4742 MATa his3-1 leu2-0 met15-0 ura3-0 Lab stock 
BJ Vam3-myc BJ3505; Vam3-His6(myc)2::URA 6 
BJ Nyv1-HA BJ3505; Nyv1-His6(HA)3::URA 6 
BJ ypt7Δ   BJ3505; ypt7::G418 Lab stock 
DKY ypt7Δ   DKY6281; ypt7::G418 Lab stock 
BJ ypt7Δ Nyv1-HA BJ3505 ypt7Δ; Nyv1-His6(HA)3::URA This study 
BJ ypt7Δ Vam3-myc BJ3505 ypt7Δ; Vam3-His6(myc)2::URA This study 
BY tor1-1 Vam7-
2xFKBP12 
BY4742; Vam7-2xFKBP12::URA This study 
BY tor1-1 Vam7-
2xFKBP12 Pfk1-
FRB-GFP 
BY4742; Vam7-2xFKBP12::URA ; Pfk1-FRB-
GFP::G418 
This study 
BY tor1-1 Pfk1-
FRB-GFP 
BY4742; Pfk1-FRB-GFP::G418 This study 
BY tor1-1 Vam7-LL-
2xFKBP12 
BY4742; Vam7-LL-2xFKBP12::URA This study 
BY tor1-1 Vam7-LL-
2xFKBP12 
  
Pfk1-FRB-GFP BY4742; Vam7-LL-2xFKBP12::URA ; Pfk1-
FRB-GFP::G418   
This study 
BY tor1-1 Vam7-
2xFKBP12 + FRB-
GFP 
BY4742; Vam7-2xFKBP12::URA ; pRS415-
TEFpr-FRB-GFP (LEU) 
This study 
CUY2675 GAL-
HOPS Vps41-TAP 
MATa/alpha his3∆200 leu2D0/leu2D0 lys2D0 
met15D0/met15D0 trp1D63/trp1D63 
ura3D0/ura3D0 VPS11pr::HIS3-GAL1pr 
VPS16::natNT2-GAL1pr VPS18::KanMX-
GAL1pr-3HA VPS33::TRP1-GAL1pr 
VPS41::TRP-GAL1pr-TAP-URA3 
VPS39::HIS3-GALpr 
33 
   
CUY3238 GAL-
Vps33-16 Vps16-
TAP 
MATa his3D200 leu2D0 lys2D0 met15D0 
trp1D63 ura3D0 VPS33::HIS3-GALpr 
Vps16::TRP-GAL1pr-TAP-URA3 
33 
   
CUY4307 GAL-
Vps39-11 Vps39-
TAP 
MATa/alpha his3D200 leu2D0/leu2d0 lys2D0 
met15D0/met15d0 trp1D63/trp1D63 
ura3D0/ura3D0 VPS11pr::HIS3-GAL1pr 
VAM6pr::KanMX-GAL1pr VAM6::TAP-URA3 
33 
   
 13 
CUY4895 GAL-
CORVET Vps8-TAP 
MATa/alpha his3D200 leu2D0/leu2D0 lys2D0 
met15D0/met15D0 trp1D63/trp1D63 
ura3D0/ura3D0 VPS11pr::HIS3-GAL1pr 
VPS16::natNT2-GAL1pr VPS18::KanMX-
GAL1pr-3HA VPS33::TRP1-GAL1pr 
VPS8::TRP-GAL1pr-TAP-URA3 VPS3::HIS3-
GALpr 
33 
   
CUY8919 GAL-
Vps33-TAP 
MATa his3D200 leu2D0 lys2D0 met15D0 
trp1D63 ura3D0 VPS33::HIS3-GALpr-TAP-
URA3 
33 
 
 
 
 
Table S2: Primers used for genetic manipulations 
Primer Sequence 
Fw Vam3-myc ATTATAATAGTTGTGTGCATGGTGGTATTGCTTGCTGTATTAAGTTCCC
ACCACCATCATCATCAC 
Rv Vam3-myc TAATCTCCTTAAACGCGCATTGAGCACAGACTTTCTGGTAGACCCACTA
TAGGGAGACCGGCAGATC 
Fw Nyv1-HA ATTATACTATTTGTAAGTGCTGCTTTCATGTTTTTCTATCTGTGGTCCCA
CCACCATCATCATCAC 
Rv Nyv1-HA GTAAATAAAAAAAAAGGGGAGCTGTCCCACGACAATAACATTAATACTA
TAGGGAGACCGGCAGATC 
Fw Pfk1 FRB-
GFP 
GGTAGATTAAAGTTGAGAGCTGAGGTAGCCGCTTTAGCCGCTGAAAAC
AAAGGTGGTGGTGGTGCTAGCATCCTCTGGC 
Rv Pfk1-FRB-
GFP 
CATGCCATTTTTACCTCCTTTTGCTTAACTTAAACTTTTCATTGCAATCAT
TCGATGAATTCGAGCTCG 
Fw Vam7-
2xFKBP12 
GGAGGTTACAGATAGCCAACAAGAAGGCTAGACATTTTAACAACAGTG
CTGGTCGACGGATCGGTGACGGTGCTGGT 
Rv Vam7-
2xFKBP12 
TAGTACAAATATACTCTCAGGATTTGTAACCCGGATAGTAACTCATTAAT
TCGATGAATTCGAGCTCG 
Fw Vam7-LL-
2xFKBP12     
GGAGGTTACAGATAGCCAACAAGAAGGCTAGACATTTTAACAACAGTG
CTAGTCTAAGTGGTGGTGGTGGTTCTGGAGGAGGAGGATCCGGTGGT
GGAGGAAGTGGAGGTGGAGGTGCTGCCGCAGGTGACGGTGCTGGTTT
AATT 
Fw FRB-GFP CCCAAGCTTATGATCCTCTGGCATGAGATGTGGC 
Rv FRB-GFP CGAGCTCTTATTTGTATAGTTCATCCATGCCAT 
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Supplementary Figures 
 
Figure S1: Full scans of blots shown in the manuscript 
 
Red boxes indicate the cropped regions. Molecular weight markers are indicated in 
the respective figures.
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